BENDAMUSTINE-ACCORD 25 MG 5 VIALS

PHARMACOLOGY:BENDAMUSTINE IS AN ALKYLATING AGENT (NITROGEN MUSTARD DERIVATIVE). USE: LABELED INDICATIONS CHRONIC LYMPHOCYTIC LEUKEMIA: TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) NON-HODGKIN LYMPHOMA: TREATMENT OF INDOLENT B-CELL NON-HODGKIN LYMPHOMA (NHL) WHICH HAS PROGRESSED DURING OR WITHIN 6 MONTHS OF RITUXIMAB TREATMENT OR A RITUXIMAB-CONTAINING REGIMEN.